Compare Citius Pharmaceuticals Inc (CTXR) vs Hims and Hers Health Inc (HIMS) Price & Performance

Citius Pharmaceuticals IncTrade

Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs Hims and Hers Health Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Hims and Hers Health Inc trades at $30.75 (market cap $7.12B). The key difference: Hims and Hers Health Inc is far larger — about 355.8× Citius Pharmaceuticals Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

	CTXR	HIMS
Market Cap	$20.01M	$7.12B
Sector	Health	Health
52-Week High	$1.82	$62.76
52-Week Low	$0.48	$14.52
Enterprise Value	$16.23M	$7.82B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTXR

Citius Oncology appoints Jonathan Peri as new independent board member to strengthen governance.PRNewsWire · 4 hours agoBullish View details →

HIMS

Hims & Hers reports strong Q2 revenue growth but wider loss amid legal challengesAndrew Wynn · 18 hours agoBearish Anthropic to embed permanent watermarks in EU AI content; Sea Limited beats Q2 revenue; 7Up refreshes flavor and branding.Seeking Alpha · 22 hours agoNeutral Hims & Hers Q2 revenue beats estimates but loss widens due to restructuring chargesProactive Investors · 1 day agoNeutral View details →

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.